2026 Could Be Called the 'Year of the Bubble' on Wall Street
January 11, 2026, 7:31 AM EST. The author argues 2026 could be remembered as the 'Year of the Bubble' on Wall Street, with up to four bubbles at risk of bursting. After three straight years of double-digit gains, major indices still face headwinds as 2026 nears. The piece highlights Quantum Computing as the most conspicuous candidate: four pure-play stocks – IonQ, Rigetti, D-Wave Quantum, Quantum Computing Inc. – have surged since late 2024 but remain unprofitable and heavily capital-burnt, with rich price-to-sales ratios. Analysts say commercialization will take years, keeping these names vulnerable to dilution. By contrast, Artificial Intelligence is further along, driven by Nvidia and Palantir, which have expanded demand for AI infrastructure and cloud solutions, lifting valuations. The author notes that equity gains over 2023-25 were strong, yet valuations and new tech cycles create risk into 2026.
iHeartMedia's ownership heavily tilted toward institutions, top holders control majority
January 11, 2026, 7:30 AM EST. IHeartMedia Inc. (IHRT) shows heavy institutional ownership. About 73% of shares are held by institutional investors, with Pacific Investment Management Company LLC as the largest holder at 16%, the second-largest around 12%, and CEO Robert Pittman at 2.1%. The nine largest holders together own more than half the stock, underscoring how voting power sits with a small group. The concentration risks a crowded trade (many investors share similar positions), which can magnify moves if institutional investors shift. Investors should monitor issuer fundamentals alongside ownership trends, as governance and fundamentals may diverge from price action.
Toro's ROCE at 19% Amid Growing Capital Base; Returns Remain Flat
January 11, 2026, 7:29 AM EST. Toro (NYSE: TTC) posts a steady ROCE of about 19% over the trailing twelve months to October 2025, above the Machinery sector average of 11%. The company has expanded its capital base, with total assets minus current liabilities growing, and capital employed up roughly 26% over the past five years. Yet, after a period of reinvestment at these rates, return on capital has not meaningfully improved, leaving the stock's total return profile largely flat over the last five years. Analysts' forecasts aren't included here; instead, the article notes that while ROCE remains respectable, the lack of acceleration could challenge investors seeking high-growth multiples. The takeaway: Toro demonstrates reinvestment discipline, but the market awaits clearer signs of growth or a re-rating.
FAR: AI-Generated Signals Point to Near-Term Buy for Foraco International (FAR:CA)
January 11, 2026, 7:28 AM EST. Foraco International SA (FAR:CA) received AI-generated signals dated Jan 11, 2026, 07:09 ET. Traders are advised to buy near 2.06 with a stop at 2.05; no short positions are recommended at this time. The AI feed assigns Near-term: Strong, Mid-term: Neutral, and Long-term: Weak ratings. The update highlights a near-term entry while signaling caution on longer horizons.
Dollar climbs as rate-cut bets recede after mixed payrolls and inflation signals
January 11, 2026, 6:57 AM EST. The dollar index rose to a one-month high, closing about +0.2%, as a mixed US payroll report kept rate-cut bets in check. Payrolls rose less than expected, but the unemployment rate fell and wage growth beat forecasts, supporting a hawkish tilt for the Fed. The University of Michigan's January sentiment index beat forecasts, lifting the dollar further. The survey's 1-year inflation expectations held at 4.2% while the longer-term measure rose to 3.4%. A Supreme Court ruling on tariffs adds ambiguity for the dollar depending on tariff revenue and the budget. Markets price roughly 5% for a -25 bp rate cut at the Jan 27-28 FOMC, with the Fed expected to trim less than 50 bp in 2026.
WEC Energy Group's ROE tops industry, but debt raises caution
January 11, 2026, 6:41 AM EST. WEC Energy Group posted a trailing twelve-month ROE of 12% for the period to September 2025, with net profit of US$1.7 billion and shareholders' equity of US$14 billion. The ROE is above the Integrated Utilities industry average of 8.6%. Still, a high ROE can reflect leverage rather than pure profitability. WEC's debt-to-equity ratio stands at 1.49, signaling financing risk if credit markets tighten. Debt-fueled growth can lift ROE, but may weigh on investors when borrowing becomes harder. A risks dashboard highlights at least two risks for WEC Energy Group. Investors should weigh how debt and financing conditions could affect future returns.
Jack Henry & Associates Valuation: Momentum Keeps Price Near Fair Value Amid Mixed Targets
January 11, 2026, 6:40 AM EST. Jack Henry & Associates (JKHY) has traded near $189 after a momentum run, with roughly 25% total return over 3 months and 11% over the past year. A fair value of about $188.15 sits just below the close, leaving a tight valuation gap. Analysts' consensus target runs near $185.09, with a range from $173 to $206. The narrative signals a premium valuation driven by growth expectations, yet the result is described as OVERVALUED if the fair value cannot be sustained. Ongoing bank consolidation and fintech competition could pressure the customer base and margins, challenging the assumed profitability mix. Investors must decide whether today's price reflects anticipated growth or remaining mispricing, with the full analysis outlining the earnings path and the multiple required to justify the valuation.
Is Albemarle (ALB) Still Worth Buying After a 90% Rally? Valuation Signals Undervalue
January 11, 2026, 6:33 AM EST. Albemarle's stock closed at $161.29, with a 90.3% 1-year gain and gains of 12.1% over 7 days, 21.5% over 30 days, and 12.1% year to date. The move reflects sensitivities around lithium supply, EV adoption, and expectations for longer-term battery demand. Simply Wall St rates Albemarle 2/6 on valuation. Its analysis uses a 2-stage Free Cash Flow to Equity model; the latest twelve-month FCF is a loss of about $189.8 million, with projected FCF turning positive in 2026 and rising to about $3.0 billion by 2035. The model puts intrinsic value at about $358.50 per share, implying the stock trades at roughly a 55% discount and is undervalued. Investors should weigh cyclicality, project pipelines, and the reliability of long-term cash flows.
Danny Moses urges traders to watch prediction markets, The Big Short investor says
January 11, 2026, 6:31 AM EST.Danny Moses, the investor behind The Big Short, says traders should monitor prediction markets as a real-time read on near-term outcomes. He argues these markets aggregate diverse information and reveal probabilities traditional research may miss. Moses notes that prediction markets can illuminate shifts in sentiment around events, earnings, regulatory decisions, and crises. The appeal is their price reflects collective judgment rather than a single story. He cautions liquidity and regulatory issues can distort signals. The remarks contribute to a broader debate about using frontier tools to manage risk in volatile markets.
M&T Bank insiders sell US$9.6 million of stock, signaling caution
January 11, 2026, 6:29 AM EST. Over the past year, M&T Bank insiders sold about US$9.6 million of stock, filings show. The largest move was by Independent Director John Barnes, unloading about US$3.0 million at roughly US$200 a share, a price near the then-current level around US$212. Insider selling did not include any purchases in the year. In the last three months, insiders sold about US$2.1 million and made no buys. Insider ownership stands at about US$115 million of stock, or roughly 0.4% of the company's equity. While selling can signal caution, it is a weak signal and not necessarily a call to action. MT Bank profits have been growing.
Marsh & McLennan insiders mostly selling; Vice Chair leads with US$480k share sale
January 11, 2026, 6:27 AM EST. Marsh & McLennan Companies Inc. (NYSE: MMC) saw insiders sell more stock than they bought over the last 12 months. The standout was Vice Chair Martin South, who dumped about US$480,000 of shares at US$240 each, a price above the latest close, which muted negative implications. Overall, insider transactions show net selling for the period. Insider ownership stands at about 0.08% of MMC, roughly US$73 million, indicating a reasonable alignment with shareholders but not a standout stake. There have been no insider transactions reported recently. Investors should monitor insiders activity, though such moves can be interpreted in multiple ways. Analysts note one warning sign in MMC's risk profile, underscoring the need for cautious evaluation.
Synchrony Financial posts 178% three-year TSR as dividend-driven gains outpace EPS growth
January 11, 2026, 6:25 AM EST. Synchrony Financial (NYSE: SYF) has delivered a 178% total shareholder return over three years, driven by dividends and a strong stock move. The shares rose about 160% in price over the period, while EPS grew about 15% per year. The price advance outpaced EPS growth, signaling a market re-rating as confidence built. In the last twelve months, TSR stood at 39% when dividends are included, and the stock has gained roughly 24% in the latest quarter. Analysts watch for revenue growth, but the trend suggests momentum after years of progress. Returns reflect both price appreciation and income, with dividends contributing to overall gains.
Brown & Brown (BRO) Valuation Check After Pullback and Cooling Momentum
January 11, 2026, 5:53 AM EST. Brown & Brown (BRO) trades near US$80.64 after a pullback that left a 3-month share price drop of 14.65% and a flat month. Longer-term momentum remains, with a 3-year total shareholder return of 34.23% and 5-year return of 80.13%, but valuation clues point to cooled growth expectations. The analysis flags an intrinsic discount of about 45% to a narrative fair value near US$92.29 and a 13% gap to analyst targets. At about a P/E (price-to-earnings) ratio of 27.8x, well above the US Insurance industry median of 12.9x and a broader fair of 16.5x, the stock looks undervalued on growth potential but carries execution and macro risks. Key caveats include tariffs, rate moves, and catastrophe-related softness that could pressure earnings.
Capital Southwest appears undervalued after multi-year rally, model-based valuation suggests
January 11, 2026, 5:41 AM EST. Capital Southwest trades near $22.98 as a multi-year rally meets a valuation test. The stock has posted 18.6% returns over the past year, with 3.1% weekly, 3.2% monthly gains, and 3-year/5-year gains of 76.2% and 118.2%. Simply Wall St scores it 3 of 6 on a valuation checklist, indicating undervalued on about half the checks. An Excess Returns model yields an intrinsic value of $28.33 per share, vs. a $22.98 price, an implied 18.9% discount. Base data: Book Value $16.62, Stable EPS $2.35, median ROE 14.17%, Cost of Equity $1.60, Excess Return $0.75. Traditional P/E commentary notes valuation depends on growth and risk; in this frame, CSWC looks undervalued, albeit with risk to monitor.
TD SYNNEX looks undervalued after price weakness, with DCF signaling upside
January 11, 2026, 5:40 AM EST. TD SYNNEX (SNX) trades around US$150.45, with a 1-year return of 13.8%, 3-year 40.9% and 5-year 82.9%, though YTD is down 1.9%. Coverage frames SNX as a large global IT distributor and solutions provider, with demand for hardware, software and services shaping sentiment. The stock earns a valuation score of 5/6, suggesting price alone doesn't tell the full story. A two-stage Free Cash Flow to Equity model yields an intrinsic value around US$244.50 per share, implying roughly 38.5% upside versus the current price. The stock trades at a P/E of 14.6x, below peer group 15.9x and industry 26.0x, indicating a relative discount. Details appear in the company report's valuation section.
Cardinal Health (CAH) stock valuation after a 5-year surge
January 11, 2026, 5:39 AM EST. Cardinal Health's share price sits around $201.11, with a 5-year gain of roughly 309% and a 1-year climb of 67.5% that masks volatility. The stock carries a valuation score of 3/6, indicating mixed signals across checks. A Discounted Cash Flow (DCF) model pegs intrinsic value at about $461.54 a share, suggesting the equity is undervalued by about 56.4%. Analysts project around $4.39b in free cash flow (FCF) in 2030 after about $4.46b in the latest twelve months, shaping a ten-year path. The P/E multiple sits near 29.96x, above healthcare peers and the sector; investors weigh growth expectations against risk in a healthcare distribution leader.
Sims Limited (ASX:SGM) lifts earnings on operational gains; dividend support reshapes the investment narrative
January 11, 2026, 5:38 AM EST. Sims Limited reported higher earnings driven by stronger operations and ongoing dividend contributions, reinforcing its role in the ASX 200 metals and recycling sector. The improvement highlights how its recycling-focused model can translate efficiency into shareholder returns amid regulatory costs. The market now looks to the upcoming first half 2026 results on 17 February to see if the earnings gains are sustainable, with questions about whether tighter scrap prices or softer demand could pressure margins and cash flow. For the margin and earnings resilience story, investors should weigh ongoing regulatory and decarbonization costs against operational improvements. Analysts note a long-range plan projecting revenue of about A$8.5 billion by 2028, but near-term risk remains from commodity cycles.
13 penny stocks fall 25-50% in a month; investors cautioned
January 11, 2026, 5:37 AM EST. Over the past month, 13 penny stocks have tumbled 25% to 50% as thin liquidity and volatility bite. The screening targeted firms with a market capitalisation below Rs 1,000 crore, a share price under Rs 20, and a minimum recent trading volume of 5 lakh shares. The aim was to flag low-priced but actively traded names that have seen sharp erosion in value. (Data source: ACE Equity.) Penny stocks, typically low-priced shares, can lure investors with cheap entry but carry elevated risk from limited disclosures and potential price manipulation. Without disciplined risk controls, investors risk outsized losses rather than meaningful gains.
Two AI Stocks to Buy for the Long Term: Microsoft and Tesla
January 11, 2026, 5:22 AM EST. Two AI-focused names anchor a market view that AI is a defining technology. A United Nations report projects the market rise from $189B in 2024 to $4.8T by 2033. Microsoft and Tesla sit at different ends of the AI spectrum. Microsoft leverages AI across its stack, with Azure and Office powering cloud revenue of $49B in the latest quarter, up 26% YoY; Copilot adoption rose 50% QoQ, and the company plans to double its data-centre footprint. Analysts see roughly 15% annual revenue growth to about $562B by 2030. Tesla shows strong cash generation, with operating cash flow over $15B in the trailing 12 months and about $29B in net cash, supporting ongoing AI product investments in autonomous driving.
Arizona Metals Corp. (AMC:CA) AI-generated signals outline near-term trading levels
January 11, 2026, 5:04 AM EST. Arizona Metals Corp. (AMC:CA) published AI-generated trading signals as of Jan. 11, 2026, 04:27 ET. The plan outlines a long-term framework with a buy near 0.71, target 0.91, and a stop loss at 0.71; a short near 0.91 with a target of 0.71 and a stop at 0.91. The accompanying ratings show Near: Strong, Mid: Strong, Long: Weak. The note directs readers to updated signals for AMC:CA and includes a chart reference. All times are timestamped; report credits: Rick W. as contributor, with Editor Derek Curry. Investors should treat these signals as one input and maintain risk controls.
JPMorgan crosses 5% in DroneShield; ASX:DRO traders watch next catalysts
January 11, 2026, 4:42 AM EST.JPMorgan Chase & Co and affiliates crossed the 5% substantial holder line in DroneShield (DRO.AX), per a Form 603 filing, owning about 46.48 million shares and 5.09% voting power as of Jan 7. The disclosure lists securities on loan and related arrangements. DroneShield closed at A$4.02 on Friday, up 4.42%, after a day trading 3.89-4.09. The stock has risen roughly 21% since Jan 5, with an 18.43% jump on Jan 6. In small-cap flow trades, register shifts can move prices even without new headlines. Next catalysts: late-January cash-flow update and any fresh holder notices. The company cites recent deals, including a $49.6 millionEuropean-reseller contract with Q1 2026 deliveries, an $8.2 millionWestern-military order, and a $6.2 millionAsia-Pacific contract, totaling about $97.7 million in locked-in 2026 revenue.
AI remains best game but diversification grows as rates fall, BlackRock strategist says
January 11, 2026, 4:39 AM EST. An ETF-focused segment for Invesco QQQ featured Kristy Akullian of BlackRock. The base case for the year remains constructive, with a fiscal impulse and tax cuts taking effect, plus ongoing deregulation. Akullian expects rates to fall, supporting risk-taking. On portfolio construction, she says the AI narrative is still the best game in town, but not the only one, emphasizing diversification. The AI-related basket in technology and communications services firms actually declined in price relative to earnings in 2025, suggesting opportunity as earnings growth outpaced price gains. BlackRock Investment Institute sees further upside but notes close monitoring of the labor market. The remarks reflect the ETF outlook tied to Invesco QQQ's weekly report.
Pure Storage stock undervalued on DCF after pullback, price near $66.98
January 11, 2026, 4:33 AM EST. Pure Storage (PSTG) trades near $66.98 after a recent pullback. The stock slid 2.9% over a week and 6.1% in 30 days, with a 3.5% gain over 12 months. A 3-year and 5-year performance remains strong. A DCF model puts a fair value around $76.41 per share, implying about a 12.3% intrinsic value discount to the current price, signaling the stock is undervalued on this method. The latest twelve-month Free Cash Flow is about $569 million, with analysts projecting growth through 2030 to $1,255.4 million under a two-stage FCF to equity framework. The stock's value score stands at 3/6, suggesting mixed signals and a partial screening for value. Revenue scale and market share remain focal points for sentiment on enterprise and cloud workloads.
Roblox CEO Baszucki sells $5.12 million of RBLX stock in latest insider sale
January 11, 2026, 4:23 AM EST. Roblox Corp. CEO David Baszucki sold 66,896 shares of RBLX for about $5.12 million at an average price of $76.48 per share, per an SEC filing dated Jan. 7. The insider had previously sold shares in separate sessions, including 66,896 shares on Dec. 18 at $84.73 and 66,896 on Nov. 11 at $104.53, plus 10,584 on Nov. 20 at $95.24. Roblox traded around $73.23 intraday, with roughly 11.36 million shares changing hands. In the latest quarterly results, Roblox reported revenue of $1.36 billion and EPS of -$0.37, beating consensus of -$0.44. Analysts have issued varied targets, from about $99 to $164, reflecting mixed growth expectations.
Roblox stock slides 6% after insider sale; director unloads shares
January 11, 2026, 4:21 AM EST. Roblox Corp. shares fell about 6% in Tuesday trading after an insider sold stock. Director Anthony P. Lee disposed of 59,000 shares at an average price of $79.96, for a total of roughly $4.72 million. Post-sale, Lee owned 257,258 shares, valued at about $20.57 million, an approximate 18.7% stake reduction. The deal was disclosed in a SEC filing. The stock traded as low as $76.21 and closed near $76.20, with volume of about 1.33 million versus a 5.35 million typical. Roblox has a market cap around $49.7 billion; earnings showed a per-share loss, though the quarter beat estimates on the bottom line. Analysts offer mixed views, with a Consensus around "Moderate Buy" and a target price near $133.96.
Roblox Director Anthony Lee sells 59,000 shares; ownership down 18.7%
January 11, 2026, 4:20 AM EST. Roblox Corporation (NYSE:RBLX) director Anthony Lee sold 59,000 shares on Friday, January 2, at an average price of $79.96, for a total value of $4.72 million. After the sale, Lee directly owns 257,258 Roblox shares, about 18.66% lighter. The transaction was disclosed in an SEC filing. Roblox stock traded around $81.07 at midday, up $0.12, with about 7.99 million shares changing hands, above the 7.44 million day average. The 50-day and 200-day moving averages stand at $95.83 and $113.72. The company has a roughly $53.1 billion market cap, a negative trailing P/E of 56.69, and a beta of 1.64. In the latest quarter, Roblox posted the EPS of $(0.37), beating estimates of $(0.44) by $0.07; revenue was $1.36 billion vs $1.64 billion est. Analysts expect a current-year EPS of -1.49.
Stock Market Faces Rare Historical Pattern Ahead of 2026, CAPE Ratio in Focus
January 11, 2026, 4:18 AM EST. Stocks logged triple-digit returns: the S&P 500 rose 24%, 23%, and 16% over the past three years as AI and other growth names led the rally. The environment benefited from a Fed easing cycle that began in 2024, lowering borrowing costs and boosting consumer spending. As 2026 opens, investors watch a pattern described as rare in 153 years, with history offering clues for the year ahead. Last year featured headwinds from tariff plans that weighed on earnings, though markets recovered on earnings and resilient AI demand. The discussion centers on the CAPE ratio-the S&P 500 Shiller CAPE, a valuation gauge based on prices relative to earnings-and what that measure may imply for stock returns in the new year.
Clorox at 11-year low yields 4.9%; contrarian case for 2026 passive income
January 11, 2026, 4:02 AM EST. Clorox's stock has fallen about 38% in 2025 as consumer staples underperformed. The shares sit near an 11-year low around $106, with a dividend yield close to 4.9%. The decline accompanies a multiyear turnaround to lift margins through brand optimization and an ERP upgrade. The ERP transition created near-term headwinds, and management projects fiscal 2026 organic sales flat to down 5%-9% and earnings lower. Investors are focusing on the longer horizon, where cloud-based systems, a refreshed supply chain and better data tools could cut costs and boost cash returns. Risks include execution challenges, slower macro demand and a delayed recovery in organic growth.
ETM eyes Nasdaq listing as Western push on critical minerals reshapes investment narrative
January 11, 2026, 3:46 AM EST. Energy Transition Minerals (ETM) is courting a Nasdaq listing, hiring Ballard Partners and Cohen & Company Capital Markets to bolster US policy engagement and advance its Kvanefjeld rare-earths project in Greenland. The move ties ETM to Western efforts to secure critical minerals supply chains and aligns its investment narrative with policy support for energy-transition materials. A successful listing could give ETM access to deeper US capital markets and clearer policy alignment on Greenland and critical minerals, but the stock remains pre-revenue, loss-making, and dependent on further equity fundraising. A valuation report flags an inflated price versus estimates, underscoring funding risk and potential dilution if market support fades. Investors should weigh whether today's enthusiasm translates into a sustainable business rather than a short-term rerating.
Genting Singapore stock at S$0.73 as funds turn net sellers ahead of Feb 19 earnings
January 11, 2026, 3:33 AM EST. Genting Singapore closed Friday at S$0.73, up 0.7%, but fund-flow data show institutions started 2026 as net sellers. The shares traded in a narrow range (S$0.725-S$0.735) with a 52-week span of S$0.66-S$0.80. Analysts are broadly positive: average target around S$0.878, implying roughly 20% upside. Investors await the Feb 19 earnings release for clues on revenue, margins, and the Resorts World Sentosa overhaul. Morgan Stanley flags debt funding as a viable option, with about S$5 billion still needed for the next expansion phase. A softer visitor spend or higher costs could squeeze cash returns as capital expenditure (capex) rises. Friday's close keeps the stock near the critical S$0.72 level, with a potential move toward the upper end of the year range if earnings surprise to the upside.
January 2026 Tech Stock Picks: Nvidia, Netflix Lead Nasdaq-100 Start
January 11, 2026, 3:31 AM EST. January seasonality is on investors' minds. Nasdaq-100 stocks rise in January about 70% of the time since 1985, averaging roughly 2.5%, versus S&P 500 gains about 62%. The pull reflects year-end cash, including retirement contributions and bonuses, flowing into equities. Tech names linked to AI are seen as durable bets for 2026. Notable picks include Nvidia, a leading AI infrastructure supplier whose GPUs power data centers; management notes AI infrastructure spending could climb from about $600 billion annually to as much as $4 trillion by 2030. Nvidia reported about $57 billion in quarterly revenue, with $51.2 billion from data centers, and talks of resuming China sales after regulatory clearance. Netflix remains a top streamer with more than 300 million subscribers in 190 countries. A third Nasdaq-100 tech stock also factors into the buy list.
IBM downgraded to Hold by Wall Street Zen; analysts adjust ratings and targets
January 11, 2026, 3:24 AM EST.IBM was downgraded to Hold by Wall Street Zen from Buy in a Sunday note. Other brokers moved on IBM: Stifel Nicolaus lifted its price target to $325 and kept a Buy. Weiss Ratings upgraded IBM to Buy. Morgan Stanley trimmed its target to $252 and set Equal Weight. Erste Group Bank upgraded to Buy, and RBC lifted its target to $350 with an Outperform rating. Market participants show a mixed consensus: one Strong Buy, ten Buy, five Hold, and one Sell per MarketBeat, with a Moderate Buy overall and a $301.85 average target. IBM traded near $304.36, above a 50-day line of $303.55 and near a 200-day average of $281.97. The stock's last quarterly results beat on EPS and revenue; next year earnings are seen around $10.78. Norges Bank bought a new stake in the second quarter.
Optimum Communications trims price target to $2.25 as fair value sits at $2.38; antitrust suit and name change to OPTU
January 11, 2026, 3:22 AM EST. Analysts trimmed Optimum Communications' 12-month price target to US$2.25 from US$3.50, while the model fair value stays at US$2.38 using a 12.5% discount. The revision ties value more to whether the company can execute planned operational changes. Raymond James maintains an Outperform rating (the stock is expected to beat the market), noting potential margin gains from cost controls even as targets fall. Bearish notes warn that the lower target reflects near-term execution risk. Separately, Optimum filed an antitrust lawsuit in New York over an alleged cartel blocking debt buybacks. Altice USA will rename to Optimum Communications, Inc. and switch the NYSE ticker to OPTU later in 2025, aligning the listing with the brand. The central valuation remains US$2.38.
J.B. Hunt Valuation Under Scrutiny After Momentum Push
January 11, 2026, 3:21 AM EST. J.B. Hunt Transport Services (JBHT) closed at US$206.85 as momentum remains intact. The stock has surged 49.76% over 90 days and posts a 1-year total return near 20%. Analysts' consensus target sits at US$159.38, with a high of US$180.00 and a low of US$133.00. A full narrative estimates a fair value of US$175.65 (labeled OVERVALUED). The current P/E is 34.4x, above the transportation sector and near peers; the projected fair ratio is 17.4x. Risks include cost inflation, higher insurance premiums, and softer demand in Final Mile services. The debate centers on whether the rally prices in growth or if downside risk remains as valuation gaps persist.
Par Pacific Holdings valuation after recent share moves
January 11, 2026, 3:20 AM EST. Par Pacific Holdings (PARR) traded at US$37.16, with a 3.7% year-to-date gain and a 1-year total shareholder return of about 114%. A 1-month rise of 8.5% hints at cooling and risk reassessment. The stock's discount to analyst targets and intrinsic value raises the question of upside. Analysts' consensus target sits at $31.50, with a range from $23.00 to $39.00. A separate narrative pegs fair value at $47.38, about a 21.6% discount to the last close, using a 7.25% discount rate. That scenario assumes margin rebuilding and earnings recovery despite likely revenue declines. Risks include regional concentration in Hawaii and the Western US and exposure to older refinery assets.
FedEx valuation after rally: DCF suggests intrinsic value around $304 vs $312 share price
January 11, 2026, 3:19 AM EST. FedEx trades around $312 a share after a stretch of gains, up about 6.6% in a week and 9.9% over 30 days. The stock is up 18.1% year-to-date and higher over longer horizons. The assessment shows a valuation score of 2/6, indicating modest undervaluation on two checks. A DCF model using a two-stage approach yields an intrinsic value of about $304.44 per share, implying the stock is roughly 2.6% above that estimate. The P/E stands at 16.96x, just above the logistics sector's 16.14x. In short, FedEx appears fairly valued but sensitive to changes in growth expectations; monitor earnings or capital allocation on your watchlist.
AB Dynamics shares down 42% in five years despite earnings growth (LON:ABDP)
January 11, 2026, 3:18 AM EST. AB Dynamics plc (LON:ABDP) has seen its shares fall 42% over five years, even as EPS grew about 24% annually and revenue rose 15%. The stock slid 27% in the past year, underperforming the AIM market, which rose roughly 28%. The dividend yield is modest, around 0.7%. The balance sheet has strengthened, but last year's price action suggests investors question the path to sustainable value. While earnings growth outpaced the price, the market remains cautious about valuation. The gap between improving fundamentals and lower prices highlights ongoing uncertainty for shareholders.
G2 Goldfields GTWO Valuation Check After Momentum; DCF Signals Far Higher Fair Value
January 11, 2026, 3:16 AM EST. G2 Goldfields (TSX:GTWO) trades at CA$6.67, after a period of momentum. Over the last week the stock rose 4.38%, about 39% in the past month, and 71% in three months. The 1-year total shareholder return is roughly 181%, with a five-year gain exceeding tenfold. The shares fetch a 16.9x price-to-book, well above the Canadian metals and mining average of 3.3x and peer average of 8.7x. The company remains unprofitable, reporting a net loss of CA$11.40m on revenue of CA$683,760. A discounted cash flow model shows fair value near CA$130.38 per share, versus the current price. The gap raises questions about whether the market is pricing asset potential or overly optimistic growth. Key risk: development delays at Oko Ghanie. Analyst target: CA$8.08.
FirstCash Holdings (FCFS) valuation flags amid 56% annual rally
January 11, 2026, 3:14 AM EST. FirstCash Holdings trades around $164.91 a share after a 56% one-year gain. On a six-test valuation, it scores 1/6. The company is viewed as a pawn lender with regulatory risk sensitivity. In the Excess Returns model, with a Book Value of $49.84 and a Stable EPS of $5.43, and a Cost of Equity of $3.84, the intrinsic value comes out at $73.61 per share – implying overvaluation of 124.0% versus the current price. The analysis frames whether investors should look beyond earnings to capital efficiency. The report also notes P/E as a shorthand, reflecting market expectations built into the price. Investors should weigh regulation and credit cycles before chasing the rally.
AMETEK shares hover near $210 as DCF signals valuation gap
January 11, 2026, 3:12 AM EST. AMETEK trades near $210.64 a share, with a 0.7% weekly gain, a 4.4% rise in the past month, and a 20.4% gain over the last year. The stock has attracted attention as investors weigh quality industrial names and the broader capital goods sector. In our valuation checks, AMETEK scores 1 out of 6, and a Discounted Cash Flow model points to an intrinsic value of about $175.22 per share. At roughly $210.64, the market price implies the stock is about 20.2% above that cash-flow based value, i.e., overvalued on this framework. The stock also trades at a P/E of about 33x, versus an electrical industry average near 31x. Investors should consider how much of the current price reflects earnings momentum versus longer-term cash generation.
Evoke fair value shifts as takeover terms clash with UK gaming tax headwinds
January 11, 2026, 3:10 AM EST. Evoke's fair value moved from £0.82 to about £0.76 a share as analysts weigh a takeover anchor against UK gaming tax and growth risks. The valuation uses the US$11.00 per-share cash offer and JPMorgan's revised 66 GBp target as a reference if the deal closes. But concerns around a roughly 35% blended UK gaming tax rate and softer growth temper upside. Investors should watch how new information shapes the narrative. Evoke's board has launched a formal review of strategic options, with Morgan Stanley and Rothschild as advisers, though there is no certainty any transaction will occur. Jefferies remains constructive on Evoke and peers; JPMorgan and Laidlaw have grown cautious.
Is American Airlines Group a value opportunity after recent rebound?
January 11, 2026, 3:08 AM EST. American Airlines Group trades around $15.99 a share, after a 3.3% weekly gain and a 6.9% monthly rise; the last 12 months show a 13.0% drop, with five-year performance at 1.5%. The mix underscores risk and upside as investors weigh ongoing operating headwinds against a long-run recovery. A simple value screen scores 4 of 6. A DCF model – using a 2-stage approach and trailing free cash flow (FCF) of about $1.03 billion – yields an intrinsic value of $33.97 a share, implying a roughly 53% discount to the current price and deeming the stock undervalued on cash flows. The piece also discusses the P/E ratio, which links current share price to earnings and reflects growth expectations and risk. The takeaway: value hinges on how the airline navigates cost pressures and demand recovery.
Luckin Coffee: DCF signals ~12% overvaluation as shares hover above intrinsic value
January 11, 2026, 3:06 AM EST. Luckin Coffee's stock, ticker LKNC.Y, last closed at US$33.12 amid a mix of near-term weakness and longer-term gains. Over the past year, Luckin Coffee returned 36.1%, and over three years about 35.7%; the latest month saw a 6.4% slide, with YTD -6.5%. A DCF model using a 2-stage Free Cash Flow to Equity framework yields an intrinsic value of US$29.54 per share, versus the current price, implying the stock is about 12.1% overvalued. The P/E sits at 19.0x, below the industry average about 22.2x and far under the peer average of 64.7x. The verdict remains mixed: growth in China's coffee market supports upside, but the current price already reflects a premium.
BILL Holdings Valuation Signals Intrinsic Discount Amid AI-driven Growth
January 11, 2026, 3:04 AM EST. BILL Holdings (BILL) trades at $54.48, with a narrative fair value of $60.86 and an intrinsic discount of about 41%. The 7-day return is 7.75% and the 90-day gain 9.84%, while the 1-year total return is -34.52%, showing momentum shifts in the near term but pressure over the longer horizon. The gap to fair value reflects an expected boost from AI-powered financial operations agents and automation that could lift revenue and margins through higher retention and new pricing tiers. A discounted cash flow approach using a rate just under 10% supports a fair value above today's price. Risks include softer SMB spending and pricing pressure from larger fintech rivals.
SGX climbs on Nasdaq dual-listing push; December activity strengthens
January 11, 2026, 3:00 AM EST. SGX shares rose 1.2% to S$17.51 on Friday as regulators opened consultations tied to a proposed SGX-Nasdaq dual-listing route. December turnover value jumped 29% year on year to S$25.8 billion, while derivatives volume rose 22% to 28.3 million contracts; full-year derivatives rose 10% to 329 million. The Monetary Authority of Singapore launched a public consultation to facilitate dual listings with Nasdaq, including a single prospectus, faster registration, and certain US-style practices under safe harbour. SGX RegCo is seeking input on a Global Listing Board rulebook, with a S$2 billion market cap and a requirement to be listed on Nasdaq's Global Select Market; consultation closes Feb. 8. Iron ore derivatives climbed 51% and FX futures 43% to 8 million contracts. SGX sits near its 52-week high.
TJX Companies Stock Rating Upgraded to Buy by Wall Street Zen; earnings beat, targets, and insider sale
January 11, 2026, 2:52 AM EST. TJX Companies (NYSE:TJX) was upgraded by Wall Street Zen from hold to Buy in a Sunday report. BTIG Research reaffirmed a Buy with a $165 target; Citigroup to $168; UBS to $193; JPMorgan to $154 and overweight. MarketBeat data show a consensus Buy and an average target of $163.86. Shares opened at $157.88, near its 1-year high of $159.48. In the latest quarter, EPS beat at $1.28; revenue reached $15.12 billion. Net margin was 8.68% and ROE 58.3%. Guidance called for Q4 2026 EPS of $1.33-$1.36 and FY 2026 of $4.63-$4.66. Insider: CEO Ernie Herrman sold 24,363 shares at $151.31, cutting ownership to about 510,780 shares.
AppLovin climbs 108% in 2025 on adtech pivot and AI momentum
January 11, 2026, 2:51 AM EST. AppLovin finished 2025 up 108% as it pivots from a mobile-game maker to a pure-play adtech company. The move followed the sale of its slow-growth gaming business to Tripledot Studios for $400 million in cash and 20% equity, sharpening focus on advertising. Through the first three quarters, revenue rose 72% to $3.82 billion, while GAAP net income climbed 128% to $2.23 billion, yielding a nearly 60% profit margin. The company expanded into new verticals and relies on its Axon AI advertising technology, with momentum in Asia. Valuation remains rich, trading at a P/E ratio of 75, but management argues the growth is justified. Outlook for 2026 depends on a sturdy ad market and broader market gains, with upside still possible.
Piper Sandler Maintains Overweight on Arrowhead; Morgan Stanley Lifts Target
January 11, 2026, 2:29 AM EST.Piper Sandler maintains an overweight rating on Arrowhead Pharmaceuticals (ARWR) and raises its price objective from $70 to $100, citing Redemplo for Familial Chylomicronemia Syndrome (FCS) and stronger potency. The firm sees at least $625,000 in U.S. FCS sales in Q4 2025 and $12.3 million in 2026, noting that quarterly dosing and a $60,000 lower annual price versus Ionis' Tryngolza could make the projections conservative. It also expects positive Phase IIIRedemplo data for severe hypertriglyceridemia in Q3 2026 and potential blockbuster label expansion in 2027. Separately, on Jan. 7, 2026, Morgan Stanley keeps an Equal Weight rating and raises its price objective to $81, pointing to early ARO-INHBE and ARO-ALK7 monotherapy readouts that support fat loss and obesity prospects.
TBCH:CA Neutral Ratings Amid AI Signals; Long-Only Buy Near 25.36, Stop 25.23
January 11, 2026, 2:28 AM EST. TBCH:CA, the TD Target 2028 Investment Grade Bond ETF, holds Neutral ratings for near, mid and long horizons, as of January 11. The report shows a long-only trading plan: buy near 25.36, stop at 25.23; no short plans offered. It notes AI-Generated Signals for TBCH:CA and points readers to the update page. Dated January 11, 2026, the piece is by Quentin W., with editing by Derek Curry. Traders should verify the timestamp on the data and weigh the neutral stance against a changing rate backdrop.
Codan Upgrades FY26 Guidance as Metal Detection and Communications Drive Profit Upgrade
January 11, 2026, 2:17 AM EST. Codan (ASX: CDA) lifted FY26 guidance after a strong half-year update, with shares up about 27%. The company forecasts a 52% lift in NPAT and 29% revenue growth for H1 FY26, driven by a 46% rise in metal detection sales and progress in communications. Underlying NPAT is expanding faster than revenue, signaling operating leverage as demand in Africa and recreational markets combines with more profitable communications growth. The market awaits the 19 February 2026 H1 results to test the guidance and quantify how much of the metal-detection lift is supported by communications and to gauge exposure to gold detectors cyclicality. Risks include a downturn in gold-detection demand that could unwind momentum. Codan projects A$961.4 million revenue and A$185.4 million earnings by 2028; fair-value estimates vary widely.
Kelly Services: Mixed narrative after price-target cut and softer outlook
January 11, 2026, 2:16 AM EST. Kelly Services' narrative shifts after Barrington cuts its price target to $16 from $25, while the fair value estimate stays at $17.67. The move preserves the core valuation but reflects a softer near-term outlook amid mixed macro signals. Barrington's Kevin Steinke keeps an Outperform rating, signaling the long-term thesis remains intact even as upside is reset. Other analysts flag macro headwinds and execution risks weighing on near-term upside. Management guides Q4 2025 revenue down 12%-14% year over year, with about 8% tied to weaker federal contractor demand and a few large customers; underlying revenue could fall 4%-6%. No Q3 share repurchases were disclosed, after 742,163 shares (2.08%) were bought under the 2024 plan. The discount rate ticked to 8.20% from 8.23%.
JinkoSolar Holding valuation check after momentum and energy-storage growth
January 11, 2026, 2:15 AM EST. JinkoSolar Holding (NYSE: JKS) faces a valuation check after momentum in shares and a growing energy-storage narrative. At $27.12, the stock's 90-day return of 15.8% contrasts with a slightly negative year-to-date return and mixed longer-term TSR. The market sees momentum picking up after past weakness. The company is expanding its energy storage systems (ESS) business with higher shipments and overseas expansion, which could lift revenue and margins over time. Ongoing R&D investments are driving cell efficiency gains, supporting competitive positioning. A recent narrative put a Fair Value of $35.23, suggesting the stock is undervalued versus the current price, though risks include policy shifts, higher priced overseas orders, and pressure on gross margins. Investors should test assumptions with the provided data.
Corn futures ease on Friday as markets await USDA data; March posts weekly gain
January 11, 2026, 2:14 AM EST. Corn futures finished the Friday session slightly lower, with nearby contracts easing while March finished the week with a gain of 8 1/4 cents. Traders kept positions light ahead of Monday's USDA grain stocks and quarterly stocks report. The CmdtyView national cash price for corn slipped 1/4 cent to $4.07 1/4. Export commitments rose to 50.895 MMT as of January 1, up about 30% year over year and representing roughly 63% of the USDA's current export projection; shipments reached 27.414 MMT, about 34% of the forecast. The U.S. government data due Monday will be followed by a Reuters survey of December 1 stocks at about 12.962 billion bushels. CFTC showed managed money trimming 7,158 contracts to a net short of 16,426 as of Jan 6. South Korean tenders priced 339,000 MT of corn.
Corn Holds Steady Friday as Export Pace Outpaces Last Year Ahead of WASDE
January 11, 2026, 2:13 AM EST.Corn futures were mostly steady Friday, with some contracts fractionally lower at midday, while the cash price sits at $4.07 1/2 per bushel. The CmdtyView national price held flat. Through Jan. 1, U.S. export commitments reached 50.895 million metric tons, up about 30% from a year earlier and about 63% of the USDA's current marketing-year projection, above the 61% average pace. Actual shipments totaled 27.414 MMT, about 34% of the forecast and ahead of the 24% normal pace. Markets eye Monday's WASDE update as analysts trim stocks to around 1.985 billion bushels in a Bloomberg survey. Overnight tenders from South Korean buyers totaled 339,000 MT.
Wheat slips modestly at midday as futures pull back; export pace ahead of last year
January 11, 2026, 1:45 AM EST.Wheat futures edged lower at midday. Chicago SRW ticked down fractionally, KC HRW off 1-2 cents, and MPLS spring wheat down 2-3 cents. Export commitments updated through January 1 total 20.228 MMT, about 18% above a year ago and 83% of the USDA estimate, with shipments at 15.16 MMT, up 21% year over year. The pace sits at 61% of USDA's export forecast, versus a 57% five-year average. Traders eye WASDE due Monday, with ending stocks seen down about 5 million bushels to 896 mbu.
Deutsche Bank Maintains Buy on EchoStar, Lifts Target to $131; Citi Raises Target to $111
January 11, 2026, 1:44 AM EST. Deutsche Bank reiterated a Buy rating on EchoStar (SATS) and raised its price objective to $131 from $97, implying about 28% upside. The Fly reported the move, with catalysts cited: the prospective sale of EchoStar's AWS-3 paired spectrum, the closure of the Dish creditor case, potential deals with tower providers, and a possible SpaceX IPO. The bank also notes interest from Verizon and T-Mobile in the spectrum licenses. In a separate note, Citi analyst Michael Rollins lifted SATS' target to $111 from $87 and kept a Neutral rating, referencing market chatter around SpaceX's valuation. EchoStar designs, develops, and distributes set-top boxes and related services for DTH providers. Investors should weigh the spectrum upside against other opportunities.
Novartis (SWX:NOVN) stock appears undervalued after gains, driven by DCF analysis
January 11, 2026, 1:43 AM EST. Novartis trades around CHF 114.04 per share, with recent performance uneven: up 4.1% in the past week, 8.1% over 30 days, and 5.1% year-to-date. Longer horizons show stronger gains: 29.7% in the last 12 months, 59.5% in three years, and 71.0% in five years. A valuation check from Simply Wall St places the stock on a 5 of 6 value score. The DCF model – a two-stage Free Cash Flow to Equity framework – yields an intrinsic value of about CHF 263.87, implying a about 56.8% discount to the current price. The P/E ratio sits at 19.0x, below the sector average of ~23x and peers around 86.3x, suggesting the stock looks cheaper on earnings grounds, though broader risks remain.
CBA stock near A$153 ahead of CPI data and RBA decision; investors eye Feb results
January 11, 2026, 1:42 AM EST. Commonwealth Bank shares finished Friday at A$153.22, down 0.08%. Markets shift focus to January inflation data due Jan 28 and the RBA policy decision in early February. CBA will report its half-year results and an interim dividend on Feb 11, with the ex-dividend date Feb 18. The stock trades like a rate-sensitive play, with net interest margin and loan losses guiding profits as competition dims margins. Westpac, ANZ and NAB posted smaller losses. A hotter inflation print or firmer RBA rhetoric could lift yields and pressure banks, while mortgage strain could temper the dividend narrative. Investors await guidance amid a mixed sector backdrop and a pending U.S. jobs report and a Supreme Court decision affecting global risk sentiment.
DBS, OCBC hit records as Singapore STI climbs on SGX
January 11, 2026, 1:41 AM EST. Singapore's stock market kicked off 2026 on a firm note as financials led gains. DBS Group surged above $58 to record highs before closing at $57.60, while OCBC topped $20 intraday and ended at $19.80. Banks supported the Straits Times Index (STI), lifting it above 4,700 and fueling talk of a move toward 5,000 this year. Analysts say income-focused investors may find dividend yields above 5% appealing if earnings stay resilient. UOB stands out on valuation, with a projected yield around 5.8% based on Jan 5 close of $35.50. SGX rose more than 2% as the exchange rebranded its equities unit to SGX Stock Exchange during a year celebrating the STI's 60th anniversary.
BofA Keeps Neutral on Lumentum; PT Raised; Morgan Stanley Lifts PT
January 11, 2026, 1:31 AM EST. Lumentum Holdings Inc. (NASDAQ:LITE) remains among 2025's top performers, as BofA keeps a Neutral rating and lifts its price target from $210 to $375, citing stronger demand for optical transceivers and components alongside ongoing supply tightness. The Fly reported the update on Dec. 16, 2025. Separately, Morgan Stanley reiterates Equal Weight on LITE and boosts its target from $190 to $304, noting the AI trade has broadened gains for optical names through mid-2026. As of Jan 6, 2025, LITE trades higher year-to-date, with the stock up 4.72%. Lumentum is a California-based technology company.
Bloom Energy BE stock attracts smart money after $600 million credit line
January 11, 2026, 1:30 AM EST. Bloom Energy (BE) shares jumped 14% after Forbes on Jan. 5, 2026, citing a $600 million credit line that boosts liquidity and capex flexibility for AI-related infrastructure and datacenters. Trading volume rose with the price as the market recovered from December. The facility is seen reducing risk around expansion and supporting onsite power generation growth amid rising energy demand from AI. The company posted a gross margin of 31.2% and a negative pre-tax profit margin of -14.8%. The Fly on Dec. 29, 2025, said Clear Street kept a Hold rating and lifted the price target to $58 from $50, raising 2026 and 2027 revenue estimates to $3.33 billion (up 2% and 9%). BE remains a notable player in the energy transformation, though some AI stocks offer greater upside with lower risk.
EMCOR Group (EME) Seen Undervalued After Five-Year Run, DCF Signals 29% Gap
January 11, 2026, 1:29 AM EST. EMCOR Group (EME) trades near $646.27 after a five-year run that has doubled or more, about 6x. Over the past week, shares rose 1.2%; month 3.6%; YTD 1.2%; and 1-year returns hit 38.6%. The stock carries a valuation score of 5/6, suggesting it is undervalued on most checks. A Discounted Cash Flow (DCF) model-using a two-stage Free Cash Flow to Equity approach-yields an intrinsic value of about $913.95 per share, versus $646.27 today, implying roughly 29.3% undervalued. The model uses a latest twelve-month FCF of about $1.15 billion and analyst estimates through 2029 of $2.01 billion. On a price-earnings basis, EMCOR trades at 25.59x earnings, below the construction industry average of about 33x. Verdict: multiple signals point to value, though headlines may lag fundamentals.
AutoNation valuation under review as shares hover around $216; fair value seen at $238
January 11, 2026, 1:28 AM EST. AutoNation (AN) trades at $216.38, with a 7-day return of 4.79% and a year-to-date gain of 4.79%. The stock's one-year total shareholder return is 26.66% and five-year TSR 191.74%, underscoring sustained momentum. A widely cited narrative values AutoNation at about $238.10, implying an intrinsic discount of roughly 26% and upside from the current price. The fair value rests on projecting revenues, profits and per-share earnings and discounting at 11.98%. The story assumes gradual revenue growth, margin uplift, rising earnings, ongoing share repurchases and a lower future P/E versus peers. Benefits cited include industry consolidation, disciplined capital allocation and scale-driven margin leverage. Key risks: faster adoption of direct-to-consumer/online models and accelerated EV uptake that could erode aftersales margins. Markets could shift the narrative quickly; readers can test assumptions by building a custom AutoNation scenario.
Haemonetics Valuation: Momentum Lifts Shares but Fair Value Signals Undervaluation
January 11, 2026, 1:27 AM EST. Haemonetics Corp (HAE) trades at $82.03, with a ~3% weekly gain, a small month-late dip, and a 3-month return of 63.3%. The stock is ~7% higher over 12 months, but -4% and -35% over 3 and 5 years, highlighting a recent momentum rebound amid longer-term headwinds. A narrative fair value of $91.70 flags the shares as undervalued at current levels. Transformation efforts-divesting low-margin businesses, disciplined capital deployment, and investments in automation and digital solutions-have lifted gross and operating margins, with FY26 guidance of 26-27%. That supports higher net margins and free cash flow, potentially warranting a higher multiple. Risks: sustaining momentum in NexSys, TEG, and VASCADE, and interventional-technologies market-share pressure. This article is general in nature; readers should run their own analysis.
CommScope's RUCKUS Unveils AI-Driven Wi-Fi 7 MDU Suite; BofA Lifts COMM Target
January 11, 2026, 1:26 AM EST. CommScope Holding Co. (NASDAQ: COMM) said its RUCKUS Networks introduced a new MDU (multi-dwelling unit) package built on the RUCKUS One platform that combines Wi-Fi 7 and AI-driven solutions for multi-dwelling units. The suite, designed to support more devices per unit, lower latency and improve reliability, blends cloud automation with enterprise-grade Wi-Fi analytics. The One MDU 360 platform provides AI-driven analytics, predictive insights and role-based access for owners and MSPs to view network health, resident experience and service-level performance across portfolios. The RUCKUS Digital System Engineer lets customers manage home networks via natural language queries, auto-creates dashboards and delivers data-driven insights. The package includes H670 and R575Wi-Fi 7 access points with Bluetooth LE and Zigbee for Matter/Thread. Separately, TheFly reported Bank of America kept a Buy rating on COMM and raised its target to $23.50 after a segment sale.
Guardant Health appears undervalued on DCF, but valuation checks are mixed
January 11, 2026, 1:14 AM EST.Guardant Health closed at US$110.17, up about 8% over the last 7 days and 30 days, with a 1-year gain near 200% and a 3-year gain of 262%, while the 5-year return sits about a 30.8% decline. The stock scores 2/6 on our valuation checks, indicating it is undervalued on two metrics. A two-stage FCFE DCF yields an intrinsic value of about US$176.29 per share, implying roughly a 37.5% upside to reach fair value. The analysis also uses a price-to-sales (P/S) approach, reflecting growth expectations and risk, but the excerpt ends before details are provided. Investors should weigh this against growth prospects and perceived risk when assessing whether the price captures future potential.
On Holding (ONON) still attractive after rally, as DCF flags undervaluation
January 11, 2026, 1:13 AM EST. On Holding trades near US$49.12, up 4.6% last week but down 13.3% in the year, with a three-year return of 137.3%. The stock carries a valuation score of 1/6, suggesting weak confirmation from traditional checks. A DCF view using CHF 331.7 million in trailing free cash flow yields an intrinsic value of US$54.98 per share, implying about a 10.7% upside to the price and labeling the name undervalued on this model. The analysis notes that a P/E lens depends on growth expectations, leaving broader value questions unresolved. Investors also weigh brand strength and long-run demand for premium sportswear as a catalyst for future gains.
Hercules Capital appears undervalued after price weakness, valuation model suggests
January 11, 2026, 1:12 AM EST. Hercules Capital trades at US$18.59 amid a recent slide, with a 1.4% drop over the past week and 30 days. The stock has a 1-year return of 4.1% and 3- to 5-year gains of 88.7% and 114.9%. Simply Wall St. rates HTGC 4 out of 6 on its valuation screen, suggesting it is undervalued on four checks. The model-heavy Excess Returns approach estimates an intrinsic value of about US$21.45 a share, implying a 13.3% discount to the current price and a potential entry point for patient investors. Inputs cited include Book Value US$12.20, Stable EPS US$1.75, ROE 15.11%, and a per-share cost of equity of US$1.12. A second valuation path via P/E is noted but not detailed here.
Citizens Maintains Outperform On Terns; Price Target Raised to $57 After CARDINAL ASH Data
January 11, 2026, 1:11 AM EST. Citizens Financial Group maintains an Outperform rating on Terns Pharmaceuticals, boosting its price target to $57 from $35 after interim CARDINAL ASH data showing a best-in-class profile for TERN-701, the company's lead candidate. The firm notes strong activity after asciminib and ponatinib, suggesting potential in second-line use and a high deep molecular response that could support first-line potential. Terns reported Q3 2025 results and said an ASH 2025 abstract highlighted unprecedented Phase 1 CML efficacy data and a possible best-in-disease profile for TERN-701, with an expanded CARDINAL dataset to be presented at ASH. Cash, cash equivalents, and marketable securities stood at $295.6 million at Sept. 30, 2025, down from $358.2 million at end-2024, enough to fund planned costs into 2028. The stock fell 3.07% on Jan 6, 2026.
ABIVAX ABVX Rumored Lilly Interest; Nasdaq Inclusion Lifts Shares
January 11, 2026, 1:10 AM EST. ABIVAX Société Anonyme (ABVX) (NASDAQ:ABVX) is rumored to attract interest from Eli Lilly, per La Tribune on December 24, 2025, TheFly reported. Pre-market, shares rose $4.62 to $142.97. The company was added to the Nasdaq Biotechnology Index, with inclusion effective December 22, 2025. Guggenheim analyst Yatin Suneja raised the price objective to $175 from $150 and reiterated a Buy rating, citing the potential for obefazimod ahead of a 44-week maintenance readout. The company holds €589.7 million in cash despite high R&D-driven losses and a €15.3 million monthly burn. The stock was down 10.04% YTD as of January 6, 2026. Disclosure: None.
Six hypergrowth tech stocks to watch in 2026, led by Palantir, Nvidia and AMD
January 11, 2026, 12:42 AM EST. Six hypergrowth tech names are positioned to lead 2026 as AI, data infrastructure and cloud demand intensifies. Palantir is pivoting from government work to commercial AI software, led by its Artificial Intelligence Platform (AIP). Q3 2025 results showed 121% growth in U.S. commercial revenue and 63% overall revenue, while the AIP sales cycle shortened via five-day bootcamps and larger deals-204 deals of $1 million or more last quarter. Nvidia remains the top AI compute provider, with about $57 billion in quarterly revenue, a market cap near $4.5 trillion, and a dominant lead despite rising competition from AMD. AMD is pushing back with the MI300 series and strong leadership, aiming to expand GPU adoption. The list highlights opportunities across six global leaders in AI, data infrastructure, and cloud platforms.
Macy's (M) valuation signals undervaluation after 53% year jump; DCF shows 19% discount
January 11, 2026, 12:41 AM EST. Macy's stock closed at $23.17 a share, after a run of 53.4% over the last year. Recent moves show a mixed tape: +1.8% over the past week, -4.1% in the last month, and +1.8% YTD. The company's value checks score 4 out of 6 on the firm's framework. A discounted cash flow model using a two-stage Free Cash Flow to Equity estimates a fair value near $28.69 per share, implying Macy's trades at about a 19.3% discount to intrinsic value. The model starts from last twelve months FCF of about $678 million and projects through 2035 to roughly $743 million. The stock also trades on a trailing P/E around 12, highlighting a potential value case for a long-standing department-store operator.
Greenbrier Companies (GBX) valuation after earnings beat amid YoY revenue decline
January 11, 2026, 12:40 AM EST. Greenbrier Companies (GBX) posted a quarterly beat on revenue and earnings, but the results showed a clear YoY slowdown in top and bottom lines. The street welcomed the beat but punished the stock: a 10.27% single-day drop to $47.86 after the release. Management confirmed fresh railcar orders, a completed buyback tranche and a higher share authorization at the AGM, offering some counterbalance to the weaker annual trend, including softer margins. On the horizon, 90-day returns lag 1-year TSR, while longer-term investors have seen gains in 3- and 5-year frames. Valuation is mixed: a narrative fair value of $53.50 suggests undervalued status, but a DCF pegs fair value at about $5.16. Risks include steel-cost pressure and European facility issues.
Brookfield Infrastructure valuation under scrutiny as 1-year gains clash with near-term weakness
January 11, 2026, 12:39 AM EST.Brookfield Infrastructure (BIPC) has weakened over the past week, month and three months despite a positive 1-year total return of 18.58%. The stock trades at a price-to-sales (P/S) multiple of 1.4x, cheaper than its peers (2.1x) but above the broader Global Gas Utilities index (1x). DCF (discounted cash flow) suggests a very different picture: implied fair value around US$5.68, versus the last close near US$43.26, implying potential overvaluation if fundamental drivers hold. The company still reports a net loss of US$156 million recently, which could weigh sentiment. Analysts' targets remain above the last close. Investors should weigh short-term momentum against the longer-term valuation, and consider risks to near-term earnings.
PulteGroup Valuation Mixed; DCF Signals Undervalued Near $132
January 11, 2026, 12:34 AM EST. Shares trade around $132.20, after 11.0% gains in the past week and 23.8% in the last year. The stock's valuation picture is a mix: 4 of 6 checks point to upside while others are mixed. In the primary framework, a Discounted Cash Flow (DCF) model using a two-stage free cash flow to equity yields an intrinsic value of about $152.69 per share. With a trailing 12-month FCF near $1.56b and projections toward $2.03b in 2035, the model implies the shares are about 13.4% undervalued at $132.20. The piece also plans to compare P/E and cash-flow methods and offers an alternate valuation angle to add context amid housing-market headlines and sentiment swings.
Nat-Gas prices sink on warm US weather forecasts
January 11, 2026, 12:33 AM EST. Feb Nymex natural gas (NGG26) closed down 0.238, -6.99%, at a 2.5-month nearest-futures low. Warmer US weather forecasts for Jan 9-15 and Jan 16-23 undercut heating demand and support storage build. NatGasWeather said most of the US is forecast to warm. The EIA raised its 2025 US nat-gas production forecast to 107.74 bcf/d from 107.70; production sits near a record, with Lower-48 dry gas output at 113.5 bcf/d, +10.7% y/y. Lower-48 demand was 87.9 bcf/d, -28.1% y/y. LNG net flows stood at 19.5 bcf/d, +0.1% w/w. Thursday's EIA report showed a larger-than-expected inventory draw of 119 bcf for the week ended Jan 2. European storage at 58% full; Baker Hughes tallied 124 US nat-gas rigs, down 1 from a 2.25-year high of 130 in late November.
Ravindra Energy's high P/S raises caution as revenue trends mix
January 11, 2026, 12:32 AM EST. Ravindra Energy Limited (NSE:RELTD) trades at a price-to-sales (P/S) ratio of about 5.1x, higher than roughly half of Indian Electrical peers, where many trade below 1.7x. The elevated multiple is not easily explained by current fundamentals. The company has posted rapid recent revenue growth, but revenue declined about 23% from three years earlier. The broader Electrical industry is expected to grow around 28% in the next year, suggesting a premium may be difficult to justify. Analysts have not published estimates for Ravindra Energy, limiting consensus guidance. The analysis cautions that a high P/S relative to peers may imply higher risk if growth slows. Investors may face disappointment if the multiple does not tighten to reflect weaker revenue trends.
Walmart to join Nasdaq-100, replacing AstraZeneca from Jan 20
January 11, 2026, 12:31 AM EST. Walmart will join the Nasdaq-100 from January 20, replacing AstraZeneca after moving its listing from the NYSE to Nasdaq in November, a decision Reuters cited. The change puts the retailer among Nasdaq's largest non-financial names, alongside players such as Nvidia and Apple. The move expands Walmart's index presence by also including it in the Nasdaq-100 Equal Weighted Index and the Nasdaq-100 Ex-Tech Sector Index when markets open. For clarity, the Nasdaq-100 is a benchmark of big non-financial Nasdaq-listed companies; the Equal Weighted variant assigns equal weight to each member, while the Ex-Tech index excludes technology firms. Companies pursue such shifts to reach different investor groups and potentially reduce listing and compliance costs, and to benefit from Nasdaq's technology platform.
Brainbees Solutions (NSE:FIRSTCRY) 3.7% pullback as institutions weigh exits amid year-long losses
January 11, 2026, 12:30 AM EST.Brainbees Solutions Ltd., trading as FIRSTCRY on the NSE, slipped 3.7% last week, widening its one-year decline to about 49%. With institutional investors accounting for roughly 27% of the stock and the six largest holders controlling about 51%, the shares may swing on big traders' moves. The top holder is SB Investment Advisers (UK) Limited with 20%, followed by Mahindra & Mahindra Limited at 8.6% and SBI Funds Management Limited at 8.2%. The CEO, Supam Maheshwari, owns about 5.2%. The concentration implies pressure on the price if large holders dilute positions. No hedge funds own the stock, according to the latest data. Investors should monitor ongoing flows from these groups as profits and losses align with ownership shifts.
Six Flags (FUN) appears undervalued after 65.6% one-year drop, DCF shows 72.8% gap
January 11, 2026, 12:29 AM EST. Six Flags Entertainment trades at $15.94, after a 1-year drop of 65.6% and a 3-year decline of 60.3%. The stock has risen 2.9% on the week and 6.9% in 30 days as investors reassess risk in US consumer services and theme parks. A 5/6 value score accompanies questions about price versus fundamentals. A 2-stage DCF model using a FCFE approach gives an intrinsic value near $58.50 per share, implying about 72.8% undervalued against the current price. The model assumes a trailing-twelve-month FCFE loss of $93.63 million, with projections to 2029. A P/S ratio of 0.52x sits below the Hospitality industry average.
Canada Goose GOOS Valuation After Recent Share Price Strength
January 11, 2026, 12:28 AM EST. Canada Goose Holdings (TSX: GOOS) trades near CA$18.36 after a year of gains. The stock rose about 30 days 4.08% and posted a 12-month total return 27.23%, with longer-term results softer. A narrative fair value of CA$20.12 sits above the current price, underscoring the assumptions behind the upside. The shares trade at a P/E 67.5x, well above North American Luxury industry at 23.6x and peers at 61.7x, and above a fair multiple of 27x. Growth drivers include faster product innovation and expansion into non-winter categories, broadening seasonality and supporting margins. Risks include softer UK/Japan traffic and higher marketing spend. The path to closing the gap depends on durable revenue growth and a stronger earnings lift, versus a more challenging travel backdrop.
Komatsu (TSE:6301) shows undervaluation after multi-year gains, per DCF analysis
January 11, 2026, 12:27 AM EST. Komatsu trades around ¥5,187 in Tokyo, after multi-year gains. Over the last 12 months, returns sit at 28.9%, with 3-year and 5-year gains of 98.1% and 108.6%. Simply Wall St assigns a 5/6 valuation score, flagging potential undervaluation. The analysis uses a 2-stage FCFE DCF model: latest TTM FCFE is ¥219,125.83m; projected ¥465,498.50m by 2030. Intrinsic value: ¥7,978.79 per share, implying about a 35% discount to the current price. The stock trades at a P/E of 11.32x, below the Machinery industry average. Verdict: Komatsu appears undervalued on this framework, but growth and risk matter.
BioStem Technologies valuation under scrutiny after recent share-price strength (BSEM)
January 11, 2026, 12:26 AM EST. BioStem Technologies (BSEM) shares jumped 17.6% in the latest session, with gains extending over the past week, month and quarter. The move follows a mixed longer view: a 1-year total return down 66.7% but a 5-year gain of 199.4%, suggesting renewed momentum. The stock last closed at US$5.00 and trades on a P/E of 4.2x-well below the US Pharmaceuticals industry average of 19.6x and peers at about 9.3x. Earnings rose 27.4% year over year; ROE is 40.4% and revenue growth is minimal at roughly 0.1% annually. The stock shows an intrinsic discount of about 82% alongside an analyst target well above the last close. A discounted cash flow model puts fair value near US$27.53, creating a sizable valuation gap amid execution risks.
Air Canada seen undervalued by DCF, despite recent share-price weakness
January 11, 2026, 12:25 AM EST. Air Canada (TSX: AC) has traded choppily as investors weigh industry risk against travel-demand recovery. In the last month, the stock rose 5.4%; over one year it is down 11.2%, and over three years down 10.9%. Simply Wall St gives a 6/6 valuation score. A two-stage Discounted Cash Flow to Equity model (DCF; discounted cash flows) puts intrinsic value at CA$55.26 a share, implying a ~64.8% gap to the current price and an undervalued read. The stock trades at P/S of 0.26x, far below airline peers (0.65x) and a 26.26x peer average. Context matters: growth and risk drive multiples, so the fair ratio is 1.13x. The result hinges on demand and cost dynamics.
Tilray Brands valuation under scrutiny after share weakness; fair value eyed at $16.17
January 11, 2026, 12:24 AM EST. Tilray Brands (TLRY) faces no single headline, but weaker momentum across cannabis, beverage, distribution and wellness segments. The stock rose 0.5% today but trails negative returns over the past week, month, three months and year. With a last close at $9.18, momentum has cooled: 30-day price return down 24.44% and 1-year TSR down 25.37%. Bulls point to a fair value around $16.17, implying a sizable gap between price and implied worth. The balance sheet remains robust, with substantial cash and ongoing debt reduction, supporting expansion and acquisitions; but ongoing net losses and slower U.S. cannabis progress introduce risk. Investors should weigh dilution risk and the longer-haul margin path when forming a thesis.
Surgery Partners fair value trimmed as analysts reset expectations
January 11, 2026, 12:09 AM EST. Analysts trim targets as the fair value for Surgery Partners settles around $25.45 per share, shy of the prior $25.73. The update reflects models reset for payer mix pressures, softer volumes, and a slower acquisition pace, not a full derailment of the story. The discount rate climbs to about 8.60%, signaling cautious earnings visibility while core growth stays largely intact. On the bullish side, Mizuho, RBC Capital, BofA, and Jefferies keep positive or Outperform ratings even as they trim targets, citing a favorable M&A backdrop and balance-sheet progress. On the bearish side, Barclays cuts to $18; Mizuho to $22, with volume headwinds and payer-mix risk underpinning the downgrades. Overall, near-term pressures temper price targets across firms.
Syrma SGS Technology's High P/E Reflects Strong Earnings Outlook, Analysts Say
January 11, 2026, 12:08 AM EST. SYRMA trades at a P/E of 60.4x, well above India's market average near 24x. The gap signals growth expectations more than current profits. Last year delivered a 112% rise in net income, and three-year EPS grew about 89%. Analysts expect about 33% annual earnings growth over the next three years, faster than the market's ~20% pace. That outlook helps justify the premium, though a slowing trajectory could test investor confidence. In essence, the high P/E mirrors a belief that earnings will sustain their momentum. Risks exist; one warning sign has been flagged by analysts. Still, the stock appears priced for continued earnings expansion rather than a near-term decline.
Soybeans gain at midday on export sales; WASDE preview looms
January 11, 2026, 12:06 AM EST.Soybeans were higher at midday, with gains of 2 to 5.75 cents. The cmdtyView cash price rose 3 cents to $9.91. Soymeal futures up about 30 cents; Soy Oil futures up 30-40 points. Overnight deliveries showed 84 against January soybeans, 52 for bean meal, 166 against January soybean oil. A private export sale of 198,000 MT was reported to an unknown destination. USDA export data show commitments at 28.576 MMT as of 1/1, about 64% of the forecast and 29% of 2024/25. WASDE due Monday; 2025/26 ending stocks seen near 295 mbu, up 5 mbu. Nearby cash around $9.91, with futures above $10.
Upstart Holdings rally prices in optimism; valuation flags modest upside but stretched P/E
January 11, 2026, 12:04 AM EST.Upstart Holdings trades around $49.12 after a 7.2% weekly gain. The stock has mixed momentum: roughly flat over 30 days, up 7.2% year-to-date, down 14.9% over the last year, and up 189.1% over three years. Investors weigh the AI-driven lending thesis against near-term sentiment. Valuation: the Excess Returns model – which prices profits above the cost of equity – yields an intrinsic value of about $51.55 per share. At about $49.12, the current price sits roughly 4.7% below that estimate. The model marks the value as About Right. On multiples, the P/E is 148.36x, well above the industry average 9.49x and the peer average 10.04x. Track UPST in your watchlist and act only if the thesis fits your risk view.
Principal Financial Group valuation diverges: market price vs. DCF
January 11, 2026, 12:02 AM EST. Principal Financial Group (PFG) closed at $90.29, with a 90-day return of 13.33% and a 1-year total return of 22.86%, underscoring momentum despite a softer one-day move. The company reported revenue of $15.8 billion and net income of $1.57 billion. An Intrinsic value model points to a 57% discount to the current price, fueling the debate over whether PFG is undervalued or fairly priced. Analysts' consensus target sits around $86, with a range from $72 to $101. In contrast, a DCF result used by the report puts a fair value at about $210.65, suggesting a sizable gap between market price and discounted cash flows. Key risks cited include fee revenue headwinds and softer dental pricing.
Ducommun valuation: momentum in shares, with a DCF fair value well above current price
January 11, 2026, 12:00 AM EST. Ducommun (DCO) drew buyers as momentum persists. The shares closed near US$107.75, up 2.06% on the day and up 14.36% over 30 days, with a 1-year total return of 67.11%. Revenue was US$806.224 million and net income a loss of US$34.608 million. Analysts see a target around US$108. Our work flags a large gap to the DCF fair value of US$153.83-about 30%-while a narrative fair value sits at US$106.25. The stock trades at a P/S ratio of ~2x, below the aerospace/defense average but above a neutral 1.1x benchmark, implying potential valuation risk if optimism fades. Upside hinges on continued revenue growth (around 7.5% per year for three years) and margin gains, tempered by aerospace cycles and defense-budget volatility.
